CURRICULUM
Department | Class | Goals |
---|---|---|
Department of Medical Science | Personalized Pharmacotherapy(Subtitle: Therapeutic Drug Monitoring) | To learn about the latest knowledge about clinical pharmacokinetics, pharmacogenomics and metabolomics for personalized pharmacotherapy. |
Personalized Pharmacotherapy (Subtitle: Pharmacogenomics) |
||
Personalized Pharmacotherapy Research (Subtitle: Quantitative Clinical Pharmacology and Therapeutics) |
||
Personalized Pharmacotherapy Research (Subtitle: Designing Clinical Drug Studies) |
||
Interdisciplinary program | Seminar in Clinical Trials 1 | To understand statistical technique that is used in new drug clinical development and clinical drug studies |
Seminar in Clinical Trials 2 Interdisciplinary program |
To understand Clinical Pharmacokinetics that explains absorption, distribution, metabolism and excretion of drug | |
Molecular Pharmacogenetics | To understand theories and principles of molecular pharamacogenetics and give various examples applying them to personalized pharmacotherapy | |
Optimum Therapy in Special Patients | To understand concepts, principles and needs of Therapeutic Drug Monitoring (TDM), and investigate how to apply it to specific drugs requiring TDM | |
Advances in PK/PD Modelling | To understand principles of various pharmacokinetic models and learn how to apply them to observed data | |
Adverse Drug Reactions and Hypersensitivity | To understand adverse drug reactions and hypersensitivity, and learn the basics of applying them to real-world clinical cases and realizing personalized optimal pharmacotherapy | |
Advances in Pharmacotherapy | To understand Clinical Pharmacokinetics that explains absorption, distribution, metabolism and excretion of drug | |
Regulatory Affairs in Drug Registration | To understand regulation, approval and management system and apply them to clinical drug development | |
Clinical Pharmacodynamics and Evaluation Methods | To understand the basics of pharmacodynamics and learn how to apply it to clinical evaluation | |
Clinical Pharmacogenetics | To understand the principles of genomics and metabolomics, and apply them to precision medicine | |
Pharmaceutical Medicine | To learn methodologies of clinical drug development in pharmaceutical industry, and grasp the application cases of real drug development | |
Clinical Aspects of Drug Interactions | To understand various drug interactions considered in clinical settings, and learn how to apply and evaluate them in real clinical conditions | |
New drug development and clinical application using artificial intelligence | Students will be introduced to the basic concepts and technologies in artificial intelligence (AI) and machine learning (ML), followed by a thorough exploration how AI (ML) could be efficiently used to increase the success rate of new drug development, e.g., from the discovery of new molecular entities to pre-clinical to clinical stages, and to help clinicians and clinical pharmacists optimize drug treatment | |
Department of Clinical Medicine Sciences | Topics in Clinical Pharmacology (Subtitle: New Drug Clinical Development and Clinical Drug Studies) |
To understand statistical technique that is used in new drug clinical development and clinical drug studies |
Topics in Clinical Pharmacology (Subtitle: Quantitative Clinical Pharmacology and Therapeutics) |
To understand principles of various pharmacokinetic models and learn how to apply them to observed data | |
Topics in Clinical Pharmacology (Subtitle: Theories and Application of Clinical Pharmacology and Therapeutics) |
To understand concepts, principles and needs of Therapeutic Drug Monitoring (TDM), and investigate how to apply it to specific drugs requiring TDM | |
Topics in Clinical Pharmacology (Subtitle: Advances in Clinical Pharmacokinetics and Pharmacodynamics) |
To learn the basic clinical PK/PD knowledge regarding design, performance and evaluation of clinical trials that are required for clinical development of new drug | |
Clinical Pharmacokinetics and Pharmacodynamics | To understand the relationships between dosage, disposition and effects of drug, and the various factors that may affect to those relationships from the perspective of PK/PD, and apply them to drug development |